Company Tycoon

Gefitinib is a highly effective targeted therapy used in the treatment of non-small cell lung cancer (NSCLC). As an epidermal growth factor receptor (EGFR) inhibitor, it blocks cancer cell growth by interfering with specific molecular pathways, making it a preferred option for patients with EGFR mut...